Clinical Trial Update: Phase III Clinical Trial of Y-2 Sublingual Tablets in the Treatment of Acute Ischemic Stroke [Phase 3]

View source ↗

Summary

A completed Phase 3 trial of Y-2 sublingual tablets for acute ischemic stroke is reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Y-2 sublingual tablets (Y-2 sublingual tablets)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Stroke | Phase 3 | Status: COMPLETED